Further validation in patient-derived plasma exosomes (n = 21) using ELISA revealed significantly increased levels of THBS1 and IGFBP3, whereas APM1 levels were markedly reduced in FD patients compared with controls (Figure 4A). This evidence concerns the gene THBS1 and Fabry disease.